LENZ Therapeutics, Inc. (LENZ) Misses Q3 EPS by 59c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q3 EPS of ($0.59). Revenue for the quarter came in at $12.5 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Costco (COST) Tops Q4 EPS by 20c
• Rockwell Automation CRO to retire at end of 2026
• 37 Capital makes Colombian property payment and retires C$424,637 in debt